Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human papillomavirus vaccine formulations

Human papillomavirus vaccine formulations

US Patent 6251678 · Granted Jun 26, 2001

Estimated economic value: $192,719,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant herpes zoster vaccine composition and application thereof2025
Anti-B7-H1 antibodies for treating tumors2023
Anti-B7-H1 antibodies for treating tumors2020
Anti-B7-H1 antibodies for treating tumors2019
1B20 PCSK9 antagonists2015
1D05 PCSK9 antagonists2014
1B20 PCSK9 antagonists2012
1D05 PCSK9 antagonists2012
DNA vaccine formulations2011
Papillomavirus vaccine compositions2010
Adenovirus formulations2008
Adenovirus formulations2008